B. Riley raised the firm's price target on Cinemark to $36 from $34 and keeps a Neutral rating on the shares. The outlook reflects improved near-term assumptions driven by May domestic box office outperformance and stronger confidence in Q2 upside, but while there is potential for further gains from continued box office strength, windowing progress, and guild renewal tailwinds, much of the bullish scenario may already be reflected in valuations, leaving limited upside and a more selective stance going forward, the analyst tells investors in a research note.
